- Home
- KPTI vs SQNS Comparison
KPTI vs SQNS Comparison
Compare KPTI & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | SQNS |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.6M | 46.9M |
| IPO Year | 2013 | 2011 |
Fundamental Metrics
Financial Performance| Metric | KPTI | SQNS |
|---|---|---|
| Price | $1.58 | $2.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $16.00 | ★ $20.33 |
| AVG Volume (30 Days) | ★ 1.3M | 27.1K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.36 | $49.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.24 | $2.38 |
| 52 Week High | $10.99 | $10.93 |
Technical Indicators
Market Signals| Indicator | KPTI | SQNS |
|---|---|---|
| Relative Strength Index (RSI) | 24.52 | 46.62 |
| Support Level | N/A | $2.72 |
| Resistance Level | $2.16 | $3.20 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 35.01 | 30.43 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About SQNS Sequans Communications S.A.
Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.